Cost-effective risk reduction and quality maintenance in our clients’ projects. Providing input into development and GTM strategies, facilitating fund-raising, participating in co-development and risk sharing.
We partner with centres of excellence to drive efficient early development, getting our clients to GO/NOGO decisions faster through effective design and conduct of First-In-Human, BA/BE, Biosimilar and other early-phase studies. We have a strong network of pre-clinical services with strategic partners across the globe.
PHASE II & III
Partnering with our customers to bring products to market efficiently and effectively, saving time, reducing costs and improving quality using innovative and adaptive digital technology in clinical trials.
Our capabilities include Strategic & Needs Assessments, Study Protocol Design, Risk-Benefit Risk Management, Patient Reported Outcomes, Literature Reviews & Meta-Analyses, Biostatistics, Monitoring & Evaluation, Medical Writing & Pharmacoeconomic Training.
MARKET ACCESS SOLUTIONS
Guiding our clients in creating effective market access solutions based on Needs Assessment, Pricing & Reimbursement Strategy, Health Economics, Pharmacoeconomics and Value Propositions.
LATE-PHASE & POST-APPROVAL
Partnering with our clients with expert guidance to lead products through late phase research toward increased market access. Studies are innovative and practical and include Phase IV trials, Observational Studies, Registries & Retrospective Studies.
Read the latest Clinical Development and Outcomes Research
articles in our News Stand.
With blockchain being the world’s leading software platform for digital assets, the application of the technology in clinical trials has sparked discussion at PanAgora’s AI & Machine Learning in Clinical Trials Summit last month. In a recent article published on Applied Clinical Trials , Moe Alsumidaie held an interview with Munther Baara (Head of New Clinical Paradigms […]
The Largest International Meeting of the Thrombosis and Hemostasis Community, the ISTH 2017 Congress, is currently taking place at the CityCube/Messe Berlin in Germany. It is the 26th Biennial Congress and will run until Thursday, the 13th of July. The ISTH 2017 Congress is the foremost global meeting in thrombosis, hemostasis and vascular biology. The […]
We are delighted to share the following significant changes and positive developments which took place recently within the TCD Group. New Ownership EOH, a JSE-listed South African based Knowledge Management group, have been in negotiation with the TCD Group since the last quarter of 2015, sharing the strategic objective to expand in the field of […]